USA v. Shkreli et al
Case Number:
1:15-cr-00637
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
December 01, 2017
Feds Want Shkreli To Forfeit $7.3M, Wu-Tang Clan Album
Brooklyn federal prosecutors on Thursday said former Retrophin CEO Martin Shkreli must forfeit $7.3 million following his August conviction on securities fraud and conspiracy charges and should hand over assets including his one-of-a-kind, $2 million Wu-Tang Clan album.
-
November 28, 2017
Feds Point To Email Trove In Ex-Katten Atty Fraud Trial
Prosecutors in the trial of ex-Katten Muchin attorney Evan Greebel blanketed the jury Tuesday with email exchanges with his notorious former client Martin Shkreli discussing numerous settlement agreements that prosecutors say were wrongly used to pay off deceived investors in Shkreli's hedge funds with assets of Retrophin Inc.
-
November 27, 2017
Shkreli Mentor And Investor Says He Lied To Feds
An investor and onetime mentor of Martin Shkreli on Monday told jurors in the trial of the controversial former pharmaceutical executive's ex-attorney of how he lied to FBI agents when questioned about what prosecutors say was a sham consulting agreement with Shkreli-founded Retrophin Inc.
-
November 22, 2017
Shkreli Deal Legit, Investor Says Ex-Katten Atty Told Him
A former commodities trader and investor in one of Martin Shkreli's hedge funds and pharmaceutical company Retrophin Inc. told jurors Wednesday of how former Katten Muchin attorney Evan Greebel assured him that an allegedly sham deal to pay him off for his investment was aboveboard.
-
November 21, 2017
Ex-Galleon Trader Says He Didn't Report Shkreli To Feds
A former Galleon Group trader turned Deutsche Bank project manager on Tuesday told jurors that he never reached out to federal prosecutors about his suspicions that Martin Shkreli was engaged in a market manipulation scheme with Retrophin Inc. stock despite having dropped the dime on his old boss at Galleon.
-
November 20, 2017
Ex-Galleon Trader Details Shkreli Vendetta At Ex-Katten Atty Trial
A Deutsche Bank project manager and former Galleon Group trader on Monday told the jury weighing the fate of Martin Shkreli's former Katten Muchin attorney of how the now-incarcerated former pharmaceutical executive harassed his family over a stock ownership dispute, but came under fire on cross-examination over a trade he made on inside information while at Galleon.
-
November 15, 2017
Ex-Katten Atty Wanted Shkreli Loan Disclosed, Jury Hears
Former Katten Muchin Rosenman LLP attorney Evan Greebel warned a former Retrophin Inc. executive that a move to convert a $900,000 Martin Shkreli investment in the drug developer to a loan was a possible "showstopper" that outside investors had to hear about, a jury weighing conspiracy charges against Greebel heard Wednesday.
-
November 14, 2017
Feds Extend Immunity To Ex-Retrophin Exec Over Hacking Claim
A former executive at Martin Shkreli's drug company Retrophin Inc. struck a nonprosecution agreement with Brooklyn federal prosecutors on Tuesday and continued testifying after lawyers for accused securities fraud co-conspirator and ex-BigLaw attorney Evan Greebel accused him of hacking.
-
November 13, 2017
Ex-Katten Atty Trial Rocked By Claims Of Witness' Cybercrime
The trial of former Katten Muchin Rosenman LLP attorney Evan Greebel on charges of aiding former Retrophin Inc. CEO Martin Shkreli in a securities fraud scheme went off the rails on Monday when the testimony of a former Retrophin executive came to an abrupt halt after the defense accused him of committing a host of cybercrimes.
-
November 09, 2017
Retrophin CEO Says He Was Suspicious Of Ex-Katten Atty
Retrophin Inc.'s CEO told a New York federal jury Thursday of how he came to believe former Katten Muchin Rosenman LLP attorney Evan Greebel was helping former Retrophin head Martin Shkreli work against the pharmaceutical company after the controversial "pharma bro" was let go as Retrophin's top executive.